Sort by
Items per page

Send to

Choose Destination

Best matches for KCa3.1:

KCa3.1 Channels and Glioblastoma: In Vitro Studies. Klumpp L et al. Curr Neuropharmacol. (2018)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease. Jin LW et al. Ann Clin Transl Neurol. (2019)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma. Brown BM et al. Curr Neuropharmacol. (2018)

Search results

Items: 1 to 20 of 401


A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8+ T Cells in Head and Neck Cancer.

Chimote AA, Gawali VS, Newton HS, Wise-Draper TM, Conforti L.

Front Pharmacol. 2020 Feb 28;11:143. doi: 10.3389/fphar.2020.00143. eCollection 2020.


New Insights on KCa3.1 Channel Modulation

Manfroni G, Ragonese F, Monarca L, Astolfi A, Mancinelli L, Iannitti RG, Bastioli F, Barreca ML, Cecchetti V, Fioretti B.

Curr Pharm Des. 2020 Mar 16. doi: 10.2174/1381612826666200316152645. [Epub ahead of print]


Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in Monocytes.

Wang S, Ran Y, Chen X, Li C, Cheng S, Liu J.

Front Pharmacol. 2020 Feb 21;11:101. doi: 10.3389/fphar.2020.00101. eCollection 2020.


Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis.

Lozano-Gerona J, Oliván-Viguera A, Delgado-Wicke P, Singh V, Brown BM, Tapia-Casellas E, Pueyo E, Valero MS, Garcia-Otín ÁL, Giraldo P, Abarca-Lachen E, Surra JC, Osada J, Hamilton KL, Raychaudhuri SP, Marigil M, Juarranz Á, Wulff H, Miura H, Gilaberte Y, Köhler R.

PLoS One. 2020 Mar 9;15(3):e0222619. doi: 10.1371/journal.pone.0222619. eCollection 2020.


Indomethacin decreases insulin secretion by reducing KCa3.1 as a biomarker of pancreatic tumor and causes apoptotic cell death.

Karatug Kacar A.

J Biochem Mol Toxicol. 2020 Mar 4:e22488. doi: 10.1002/jbt.22488. [Epub ahead of print]


Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.

Papp F, Hajdu P, Tajti G, Toth A, Nagy E, Fazekas Z, Kovacs S, Vámosi G, Varga Z, Panyi G.

Int J Mol Sci. 2020 Feb 25;21(5). pii: E1568. doi: 10.3390/ijms21051568.


Synthesis of Small-Molecule Fluorescent Probes for the In Vitro Imaging of Calcium-Activated Potassium Channel KCa 3.1.

Brömmel K, Maskri S, Maisuls I, Konken CP, Rieke M, Pethő Z, Strassert CA, Koch O, Schwab A, Wünsch B.

Angew Chem Int Ed Engl. 2020 Feb 25. doi: 10.1002/anie.202001201. [Epub ahead of print]


A critical role of the KCa 3.1 channel in mechanical stretch-induced proliferation of rat bone marrow-derived mesenchymal stem cells.

Jia X, Su H, Chen X, Huang Y, Zheng Y, Ji P, Gao C, Gong X, Huang Y, Jiang LH, Fan Y.

J Cell Mol Med. 2020 Mar;24(6):3739-3744. doi: 10.1111/jcmm.15014. Epub 2020 Feb 17.


Corpus cavernosum smooth muscle cell dysfunction and phenotype transformation are related to erectile dysfunction in prostatitis rats with chronic prostatitis/chronic pelvic pain syndrome.

Wang GC, Huang TR, Hu YY, Wang KY, Shi H, Yin L, Peng B.

J Inflamm (Lond). 2020 Jan 6;17:2. doi: 10.1186/s12950-019-0233-z. eCollection 2020.


KCa3.1 channel blockade attenuates microvascular remodelling in a large animal model of bleomycin-induced pulmonary fibrosis.

Derseh HB, Dewage SNV, Perera KUE, Pagel CN, Koumoundouros E, Organ L, Snibson KJ.

Sci Rep. 2019 Dec 27;9(1):19893. doi: 10.1038/s41598-019-56412-z.


Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom.

Luna-Ramirez K, Csoti A, McArthur JR, Chin YKY, Anangi R, Najera RDC, Possani LD, King GF, Panyi G, Yu H, Adams DJ, Finol-Urdaneta RK.

Biochem Pharmacol. 2020 Apr;174:113782. doi: 10.1016/j.bcp.2019.113782. Epub 2019 Dec 25.


TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.

Bresciani E, Possenti R, Coco S, Rizzi L, Meanti R, Molteni L, Locatelli V, Torsello A.

Int J Mol Sci. 2019 Dec 24;21(1). pii: E130. doi: 10.3390/ijms21010130. Review.


Internalization and Transportation of Endothelial Cell Surface KCa2.3 and KCa3.1 in Normal Pregnancy and Preeclampsia.

Choi S, Kim JA, Oh S, Park MH, Cho GJ, Suh SH.

Oxid Med Cell Longev. 2019 Nov 23;2019:5820839. doi: 10.1155/2019/5820839. eCollection 2019.


Gal-3 (Galectin-3) and KCa3.1 Mediate Heterogeneous Cell Coupling and Myocardial Fibrogenesis Driven by βAR (β-Adrenoceptor) Activation.

She G, Hou MC, Zhang Y, Zhang Y, Wang Y, Wang HF, Lai BC, Zhao WB, Du XJ, Deng XL.

Hypertension. 2020 Feb;75(2):393-404. doi: 10.1161/HYPERTENSIONAHA.119.13696. Epub 2019 Dec 16.


Intracellular Ion Channels in Pancreas Cancer.

Patel SH, Edwards MJ, Ahmad SA.

Cell Physiol Biochem. 2019;53(S1):44-51. doi: 10.33594/000000193. Review.


The Long Non-Coding RNA-14327.1 Promotes Migration and Invasion Potential of Endometrial Carcinoma Cells by Stabilizing the Potassium Channel Kca3.1.

Zhang Y, Zhang P, Chen L, Zhao L, Zhu J, Zhu T.

Onco Targets Ther. 2019 Nov 27;12:10287-10297. doi: 10.2147/OTT.S226737. eCollection 2019.


Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3.1 channel blockers in fibrotic diseases.

Roach KM, Bradding P.

Br J Pharmacol. 2020 Mar;177(5):1003-1024. doi: 10.1111/bph.14939. Epub 2020 Feb 3. Review.


Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts.

Chung CC, Lin YK, Chen YC, Kao YH, Lee TI, Chen YJ.

Lab Invest. 2020 Feb;100(2):285-296. doi: 10.1038/s41374-019-0341-7. Epub 2019 Nov 20.


SKA-31, an activator of Ca2+-activated K+ channels, improves cardiovascular function in aging.

John CM, Khaddaj Mallat R, Mishra RC, George G, Singh V, Turnbull JD, Umeshappa CS, Kendrick DJ, Kim T, Fauzi FM, Visser F, Fedak PWM, Wulff H, Braun AP.

Pharmacol Res. 2020 Jan;151:104539. doi: 10.1016/j.phrs.2019.104539. Epub 2019 Nov 7.


Supplemental Content

Loading ...
Support Center